CRISPR Therapeutics AG
CRISPR Therapeutics develops CRISPR/Cas9-based therapies for genetic diseases through a collaboration with Vertex.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story
November 2026
October 2026
September 2026
August 2026
CRISPR Therapeutics develops CRISPR/Cas9-based therapies for genetic diseases through a collaboration with Vertex.
November 2026
October 2026
September 2026
August 2026